Cannabis legalization and regulation was noted as an issue with longtime support of a majority of voters in the state.

A new bill was introduced to California’s state assembly which would allow hemp-derived products with limited quantities of THC, alleviating the previous ban.

Kentucky launched its medical cannabis program on January 1, 2025, allowing patients with qualifying conditions to apply for ID cards.

Sales of recreational cannabis began a few months ago in the state.

A market report on hemp-derived CBD’s growing interest to be used in personal care and cosmetics, regulatory changes and natural and plant-based wellness products.

It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2024. Here is just a small snippet of some of the top articles that our readers enjoyed. See if any of your favorites made the list!

A recent study revealed the potential use of CBD to help decrease alcohol use disorder cravings.

The study analyzed data from three adult age groups on daily or near daily cannabis and alcohol use.

New York Governor Kathy Hochul recently announced that the Big Apple recently reached $1 billion in cannabis retail sales.

In late January 2025 the survey will be sent to hemp producers in six states.

Louisiana rings in the new year with new THC and CBD legislation for both the cannabis and hemp industries.

Here, we unpack key events and regulatory milestones of 2024, including rescheduling, OSHA compliance, banking, and innovations, plus we discuss the outlook for 2025.

As we begin the year 2025, let’s review the most popular trends and topics in webinars covered by Cannabis Science and Technology in 2024.

Listen to a Noid Factoid from Yasha Kahn, co-founder of MCR Labs.

Check out the complete series from our Cannabis Analysis column.